CBD Life Sciences Inc. (CBDL)

Market Cap	432.07K
Revenue (ttm)	178.45K
Net Income (ttm)	-107.44K
Shares Out	4.32B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,016,667
Average Volume	58,338,256
Open	0.0002
Previous Close	0.0002
Day's Range	0.0001 - 0.0002
52-Week Range	0.0001 - 0.0018
Beta	78.23
RSI	34.64
Earnings Date	Aug 18, 2025

About CBD Life Sciences

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 2019. The company is based in Scottsdale, Arizona.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Lisa Nelson
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: CBDL

Financial Performance

In 2023, CBD Life Sciences's revenue was $167,147, an increase of 4.31% compared to the previous year's $160,241. Losses were -$78,574, -90.86% less than in 2022.